Details for Patent: 12,059,409
✉ Email this page to a colleague
Which drugs does patent 12,059,409 protect, and when does it expire?
Patent 12,059,409 protects MYRBETRIQ and is included in one NDA.
This patent has thirty-two patent family members in twenty-three countries.
Drugs Protected by US Patent 12,059,409
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apgdi | MYRBETRIQ | mirabegron | TABLET, EXTENDED RELEASE;ORAL | 202611-001 | Jun 28, 2012 | AB | RX | Yes | Yes | 12,059,409 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Apgdi | MYRBETRIQ | mirabegron | TABLET, EXTENDED RELEASE;ORAL | 202611-002 | Jun 28, 2012 | AB | RX | Yes | Yes | 12,059,409 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,059,409
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009300752 | ⤷ Subscribe | |||
| Brazil | PI0919466 | ⤷ Subscribe | |||
| Canada | 2740342 | ⤷ Subscribe | |||
| China | 102170878 | ⤷ Subscribe | |||
| China | 105232448 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
